This topic contains a solution. Click here to go to the answer

Author Question: Your client underwent a cardiac catheterization this morning through the left femoral site. The ... (Read 36 times)

crazycityslicker

  • Hero Member
  • *****
  • Posts: 537
Your client underwent a cardiac catheterization this morning through the left femoral site. The client's left leg is now cold and pale. Which additional assessment data could you use to confirm alteration in tissue perfusion?
 
  1. diminished pulses in the left leg
  2. absence of pitting edema
  3. slight discomfort at the left femoral site
  4. capillary refill of 2 seconds

Question 2

An elderly client whose right hip was replaced yesterday reports numbness and tingling in the right leg. What should you do?
 
  1. Reassure the client that this is a normal reaction.
  2. Assess neurovascular status and report the change in condition to the physician immediately.
  3. Administer pain medication and reposition the client.
  4. Encourage the client to relax and take deep breaths.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lou

  • Sr. Member
  • ****
  • Posts: 286
Answer to Question 1

ANS: 1

Answer to Question 2

ANS: 2




crazycityslicker

  • Member
  • Posts: 537
Reply 2 on: Jul 22, 2018
Thanks for the timely response, appreciate it


miss.ashley

  • Member
  • Posts: 371
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library